MeSH term
Frequency | Condition_Probility | Female | 10 | 0.0 |
Humans | 79 | 0.0 |
Animals | 60 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Calcium/metabolism | 17 | 1.0 |
Capsaicin/pharmacology | 17 | 50.0 |
*Cation Transport Proteins | 6 | 2.0 |
Cell Line | 24 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Electrophysiology | 11 | 2.0 |
Gene Expression Profiling | 2 | 0.0 |
*Heat | 5 | 4.0 |
*Ion Channel Gating/drug effects | 2 | 50.0 |
Molecular Sequence Data | 9 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Protons | 5 | 5.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
CHO Cells | 6 | 0.0 |
Electric Conductivity | 3 | 1.0 |
Hamsters | 7 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Sequence Alignment | 2 | 0.0 |
*Temperature | 2 | 6.0 |
Pain/*metabolism | 2 | 25.0 |
Thermoreceptors/*metabolism | 2 | 66.0 |
Adolescent | 3 | 0.0 |
Adult | 6 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Male | 20 | 0.0 |
Middle Aged | 6 | 0.0 |
Receptors, Drug/*metabolism | 8 | 33.0 |
Cells, Cultured | 9 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Heat | 11 | 2.0 |
Rats | 36 | 0.0 |
Rats, Sprague-Dawley | 10 | 0.0 |
Receptors, Drug/*analysis | 2 | 40.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 42 | 0.0 |
*Cold | 2 | 3.0 |
Ligands | 6 | 0.0 |
Models, Biological | 4 | 0.0 |
Patch-Clamp Techniques | 10 | 2.0 |
Receptors, Drug/agonists/genetics/*metabolism | 4 | 80.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Fluorescent Dyes | 2 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
In Vitro | 2 | 0.0 |
Mice | 19 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Calcium Channels/physiology | 2 | 10.0 |
Cation Transport Proteins/physiology | 3 | 50.0 |
Ion Channels/physiology | 2 | 6.0 |
Neoplasm Proteins/physiology | 2 | 3.0 |
Nerve Tissue Proteins/physiology | 2 | 4.0 |
Nociceptors/physiology | 3 | 25.0 |
Receptors, Drug/physiology | 2 | 50.0 |
Arachidonic Acids/*pharmacology | 3 | 16.0 |
Comparative Study | 8 | 0.0 |
Dose-Response Relationship, Drug | 19 | 0.0 |
Ion Channels/*metabolism | 4 | 9.0 |
Child | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Administration, Oral | 2 | 0.0 |
Biological Availability | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Hydrogen-Ion Concentration | 8 | 0.0 |
Inhibitory Concentration 50 | 4 | 1.0 |
Recombinant Proteins/drug effects/genetics/metabolism | 2 | 12.0 |
Structure-Activity Relationship | 5 | 0.0 |
Binding Sites | 3 | 0.0 |
Receptors, Drug/*antagonists & inhibitors/chemistry | 2 | 100.0 |
Boron Compounds/*pharmacology | 2 | 40.0 |
Capsaicin/*pharmacology | 2 | 18.0 |
Ganglia, Spinal/metabolism | 3 | 16.0 |
Neurons/metabolism | 2 | 0.0 |
Temperature | 4 | 0.0 |
Xenopus | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Kidney/cytology/metabolism | 2 | 2.0 |
Mice, Knockout | 5 | 0.0 |
Transfection | 9 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Nociceptors/*metabolism | 2 | 50.0 |
*Protons | 3 | 17.0 |
Rats, Wistar | 3 | 0.0 |
Ganglia, Spinal/cytology | 4 | 16.0 |
Receptors, Drug/metabolism | 3 | 15.0 |
Behavior, Animal/drug effects/physiology | 2 | 16.0 |
Cell Line, Tumor | 2 | 0.0 |
Nociceptors/drug effects/metabolism | 2 | 100.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Receptor, PAR-2/agonists/genetics/*metabolism | 2 | 66.0 |
Models, Molecular | 6 | 0.0 |
Phorbol Esters/pharmacology | 3 | 2.0 |
Time Factors | 4 | 0.0 |
Nociceptors/metabolism | 2 | 66.0 |
Pain Measurement/*drug effects/methods | 2 | 66.0 |
Xenopus laevis | 3 | 0.0 |
Membrane Potentials/drug effects/physiology | 2 | 2.0 |
Phosphorylation | 4 | 0.0 |
Kidney/cytology/drug effects/metabolism | 2 | 10.0 |
Neurons/drug effects/metabolism | 2 | 4.0 |
Receptors, Drug/genetics/*metabolism | 2 | 66.0 |
Enzyme Activation | 2 | 0.0 |
Receptors, Drug/chemistry/*physiology | 2 | 100.0 |
*Ion Channels | 2 | 6.0 |
Phospholipase C/metabolism | 3 | 1.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Methionine/chemistry | 2 | 14.0 |
Mutation | 5 | 0.0 |
Rabbits | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Serine/chemistry | 2 | 1.0 |
Threonine/chemistry | 2 | 2.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Capsaicin/*analogs & derivatives/*pharmacology | 2 | 100.0 |
Diterpenes/pharmacology | 3 | 11.0 |
Guinea Pigs | 6 | 0.0 |
Receptors, Drug/*antagonists & inhibitors/metabolism | 2 | 66.0 |
Arachidonic Acids/*metabolism | 2 | 6.0 |
Endocannabinoids/*metabolism | 2 | 40.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
Ion Channel Gating/*physiology | 2 | 7.0 |
Embryo | 2 | 0.0 |
Patch-Clamp Techniques/methods | 2 | 20.0 |
Ion Channels/*metabolism/physiology | 2 | 40.0 |
Receptors, Drug/*antagonists & inhibitors | 2 | 100.0 |
Neurons, Afferent/*physiology | 3 | 11.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 2 | 1.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Adenosine Triphosphate/physiology | 2 | 11.0 |
English Abstract | 3 | 0.0 |
Neurons, Afferent/*metabolism | 2 | 11.0 |
Ion Channel Gating | 2 | 2.0 |
Temperature Sense/*physiology | 2 | 100.0 |
Sequence Deletion | 2 | 0.0 |
Diterpenes/*pharmacology | 2 | 6.0 |
